In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007–08 season for resistance. Questionnaires from physicians provided information on predisposing diseases, oseltamivir use, symptoms, and complications. Clinical data were obtained for 265 patients. In total, 183 (67.3%) of 272 viruses were oseltamivir resistant. Resistance was not associated with prior use of antiviral drugs. Symptoms and hospitalization rates did not differ for patients infected with a resistant or a susceptible virus. Oseltamivir-resi...
During the influenza season 2007-8, the proportion of seasonal influenza A(H1N1) viruses resistant ...
Contains fulltext : 81631.pdf (publisher's version ) (Open Access)In Europe, the 2...
Oseltamivir has been widely used for pandemic (H1N1) 2009 virus infection, and by April 30, 2010, a ...
During the 2007-08 influenza season, high levels of oseltamivir resistance were detected among influ...
During the 2007-08 influenza season, high levels of oseltamivir resistance were detected among influ...
Background: Antiviral susceptibility surveillance in the Netherlands was intensified after the first...
In Europe, the 2007–08 winter season was dominated by influenza virus A (H1N1) circulation through w...
International audienceIn Europe, the 2007-08 winter season was dominated by influenza virus A (H1N1)...
Abstract Background Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resis...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
In Europe, the 2007/08 winter season was dominated by influenza virus A (H1N1) circulation through w...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
In Europe, the 2007-08 winter season was dominated by influenza virus A (H1N1) circulation through w...
Background: Continuous monitoring of influenza antiviral susceptibility has become more important si...
Surveillance Findings - Influenza caused by an oseltamivir-resistant influenza A(H1N1) virus was wi...
During the influenza season 2007-8, the proportion of seasonal influenza A(H1N1) viruses resistant ...
Contains fulltext : 81631.pdf (publisher's version ) (Open Access)In Europe, the 2...
Oseltamivir has been widely used for pandemic (H1N1) 2009 virus infection, and by April 30, 2010, a ...
During the 2007-08 influenza season, high levels of oseltamivir resistance were detected among influ...
During the 2007-08 influenza season, high levels of oseltamivir resistance were detected among influ...
Background: Antiviral susceptibility surveillance in the Netherlands was intensified after the first...
In Europe, the 2007–08 winter season was dominated by influenza virus A (H1N1) circulation through w...
International audienceIn Europe, the 2007-08 winter season was dominated by influenza virus A (H1N1)...
Abstract Background Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resis...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
In Europe, the 2007/08 winter season was dominated by influenza virus A (H1N1) circulation through w...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
In Europe, the 2007-08 winter season was dominated by influenza virus A (H1N1) circulation through w...
Background: Continuous monitoring of influenza antiviral susceptibility has become more important si...
Surveillance Findings - Influenza caused by an oseltamivir-resistant influenza A(H1N1) virus was wi...
During the influenza season 2007-8, the proportion of seasonal influenza A(H1N1) viruses resistant ...
Contains fulltext : 81631.pdf (publisher's version ) (Open Access)In Europe, the 2...
Oseltamivir has been widely used for pandemic (H1N1) 2009 virus infection, and by April 30, 2010, a ...